GlycoCheck is offered at two system levels to accommodate academic university and hospital researchers and individual healthcare practitioners.

As part of our continued investment and innovation in the GlycoCheck system, there are significant new developments underway:

1. The new patented GlycoCheck 5.2 software is complete, has been fully tested and used in some new peer-reviewed published papers. The new software offers a significant upgrade to the MicroVascular Health Score™. The software adds new algorithms to measure red cell velocity in the smallest capillaries, determines the flow dependency of capillary density and glycocalyx properties, and calculates an overall Microvascular Health Score based on 100 million measurements of red cell column width in 100,000 vessels segments. We’ve also introduced two completely new reports along with easy-to-understand graphs and gauges. The 5.2 version software is available for upgrade purchase by previous GlycoCheck owners (please contact us for information).
2. GlycoCheck 5.2 software is being upgraded to offer a cloud-based Software as a Service (SaaS) model. This will allow academic research hospitals to be able to purchase the system with lower initial acquisition and hardware costs and move the ongoing expenses from the capital expenditure budget to the operating budget. In addition, for healthcare practitioners the introduction of the new cloud-based system and the SaaS option allows a price-per-test based model. The major advantage of moving to multi-core cloud servers is that it reduces the time to calculate the 100 million calculations of the video analysis and generates the final reports in just a few minutes.
3. The next generation video microscope camera is in the final stages of development. The new camera, named CapiVision™, takes advantage of all the latest upgrades in imaging quality and cost reductions in components and our ability to move to volume production. The imaging acquisition process is part of a new patent-pending camera which will incorporate autofocus and will be able to capture images of microvessels from a much larger field of view, which will bring down the time for acquisition to less than 10% of current acquisition times. We estimate that the time to acquire microvascular images from 24 different tissue sites by the new GlycoCheck 5.2 software will be reduced to 3-5 minutes, a reduction of 20-30 minutes.

New Report

The new reports in GlycoCheck 5.2 includes a Summary Report and an Extended Report displaying details. Click here to read the Summary Report and click here to read the Extended Report.